Literature DB >> 26260078

Molecular evidence for decreased synaptic efficacy in the postmortem olfactory bulb of individuals with schizophrenia.

Chijioke N Egbujo1, Duncan Sinclair1, Karin E Borgmann-Winter2, Steven E Arnold1, Bruce I Turetsky1, Chang-Gyu Hahn3.   

Abstract

Multiple lines of evidence suggest altered synaptic plasticity/connectivity as a pathophysiologic mechanism for various symptom domains of schizophrenia. Olfactory dysfunction, an endophenotype of schizophrenia, reflects altered activity of the olfactory circuitry, which conveys signals from olfactory receptor neurons to the olfactory cortex via synaptic connections in the glomeruli of the olfactory bulb. The olfactory system begins with intranasal olfactory receptor neuron axons synapsing with mitral and tufted cells in the glomeruli of the olfactory bulb, which then convey signals directly to the olfactory cortex. We hypothesized that olfactory dysfunction in schizophrenia is associated with dysregulation of synaptic efficacy in the glomeruli of the olfactory bulb. To test this, we employed semi-quantitative immunohistochemistry to examine the olfactory bulbs of 13 postmortem samples from schizophrenia and their matched control pairs for glomerular expression of 5 pre- and postsynaptic proteins that are involved in the integrity and function of synapses. In the glomeruli of schizophrenia cases compared to their matched controls, we found significant decreases in three presynaptic proteins which play crucial roles in vesicular glutamate transport - synapsin IIa (-18.05%, p=0.019), synaptophysin (-24.08% p=0.0016) and SNAP-25 (-23.9%, p=0.046). Two postsynaptic proteins important for spine formation and glutamatergic signaling were also decreased-spinophilin (-17.40%, p=0.042) and PSD-95 (-34.06%, p=0.015). These findings provide molecular evidence for decreased efficacy of synapses within the olfactory bulb, which may represent a synaptic mechanism underlying olfactory dysfunction in schizophrenia. Published by Elsevier B.V.

Entities:  

Keywords:  Olfactory bulb; PSD-95; SNAP-25; Schizophrenia; Synapse; Synaptophysin

Mesh:

Substances:

Year:  2015        PMID: 26260078      PMCID: PMC5119750          DOI: 10.1016/j.schres.2015.07.026

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  79 in total

1.  Odor hedonic capacity and anhedonia in schizophrenia and unaffected first-degree relatives of schizophrenia patients.

Authors:  Vidyulata Kamath; Paul J Moberg; Christian G Kohler; Raquel E Gur; Bruce I Turetsky
Journal:  Schizophr Bull       Date:  2011-05-26       Impact factor: 9.306

2.  Altered cortical CDC42 signaling pathways in schizophrenia: implications for dendritic spine deficits.

Authors:  Masayuki Ide; David A Lewis
Journal:  Biol Psychiatry       Date:  2010-04-10       Impact factor: 13.382

3.  Altered levels of the synaptosomal associated protein SNAP-25 in schizophrenia.

Authors:  P M Thompson; A C Sower; N I Perrone-Bizzozero
Journal:  Biol Psychiatry       Date:  1998-02-15       Impact factor: 13.382

4.  Dysregulation of olfactory receptor neuron lineage in schizophrenia.

Authors:  S E Arnold; L Y Han; P J Moberg; B I Turetsky; R E Gur; J Q Trojanowski; C G Hahn
Journal:  Arch Gen Psychiatry       Date:  2001-09

5.  Alterations of hippocampal secreted N-CAM in bipolar disorder and synaptophysin in schizophrenia.

Authors:  M P Vawter; A L Howard; T M Hyde; J E Kleinman; W J Freed
Journal:  Mol Psychiatry       Date:  1999-09       Impact factor: 15.992

6.  Structural abnormalities of subicular dendrites in subjects with schizophrenia and mood disorders: preliminary findings.

Authors:  G Rosoklija; G Toomayan; S P Ellis; J Keilp; J J Mann; N Latov; A P Hays; A J Dwork
Journal:  Arch Gen Psychiatry       Date:  2000-04

7.  Synapsin IIa controls the reserve pool of glutamatergic synaptic vesicles.

Authors:  Daniel Gitler; Qing Cheng; Paul Greengard; George J Augustine
Journal:  J Neurosci       Date:  2008-10-22       Impact factor: 6.167

8.  Dysbindin-1 is reduced in intrinsic, glutamatergic terminals of the hippocampal formation in schizophrenia.

Authors:  Konrad Talbot; Wess L Eidem; Caroline L Tinsley; Matthew A Benson; Edward W Thompson; Rachel J Smith; Chang-Gyu Hahn; Steven J Siegel; John Q Trojanowski; Raquel E Gur; Derek J Blake; Steven E Arnold
Journal:  J Clin Invest       Date:  2004-05       Impact factor: 14.808

Review 9.  Chlorpromazine equivalent doses for the newer atypical antipsychotics.

Authors:  Scott W Woods
Journal:  J Clin Psychiatry       Date:  2003-06       Impact factor: 4.384

10.  De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia.

Authors:  G Kirov; A J Pocklington; P Holmans; D Ivanov; M Ikeda; D Ruderfer; J Moran; K Chambert; D Toncheva; L Georgieva; D Grozeva; M Fjodorova; R Wollerton; E Rees; I Nikolov; L N van de Lagemaat; A Bayés; E Fernandez; P I Olason; Y Böttcher; N H Komiyama; M O Collins; J Choudhary; K Stefansson; H Stefansson; S G N Grant; S Purcell; P Sklar; M C O'Donovan; M J Owen
Journal:  Mol Psychiatry       Date:  2011-11-15       Impact factor: 15.992

View more
  8 in total

Review 1.  SNARE complex in developmental psychiatry: neurotransmitter exocytosis and beyond.

Authors:  Renata Basso Cupertino; Djenifer B Kappel; Cibele Edom Bandeira; Jaqueline Bohrer Schuch; Bruna Santos da Silva; Diana Müller; Claiton Henrique Dotto Bau; Nina Roth Mota
Journal:  J Neural Transm (Vienna)       Date:  2016-02-08       Impact factor: 3.575

2.  Postsynaptic Density-95 Isoform Abnormalities in Schizophrenia.

Authors:  Adam J Funk; Catharine A Mielnik; Rachael Koene; Erin Newburn; Amy J Ramsey; Barbara K Lipska; Robert E McCullumsmith
Journal:  Schizophr Bull       Date:  2017-07-01       Impact factor: 9.306

Review 3.  Dysregulations of Synaptic Vesicle Trafficking in Schizophrenia.

Authors:  Chijioke N Egbujo; Duncan Sinclair; Chang-Gyu Hahn
Journal:  Curr Psychiatry Rep       Date:  2016-08       Impact factor: 5.285

4.  Disrupted Olfactory Integration in Schizophrenia: Functional Connectivity Study.

Authors:  Sara Kiparizoska; Toshikazu Ikuta
Journal:  Int J Neuropsychopharmacol       Date:  2017-09-01       Impact factor: 5.176

Review 5.  Emerging Synaptic Molecules as Candidates in the Etiology of Neurological Disorders.

Authors:  Viviana I Torres; Daniela Vallejo; Nibaldo C Inestrosa
Journal:  Neural Plast       Date:  2017-02-26       Impact factor: 3.599

Review 6.  Treating the Synapse in Major Psychiatric Disorders: The Role of Postsynaptic Density Network in Dopamine-Glutamate Interplay and Psychopharmacologic Drugs Molecular Actions.

Authors:  Carmine Tomasetti; Felice Iasevoli; Elisabetta Filomena Buonaguro; Domenico De Berardis; Michele Fornaro; Annastasia Lucia Carmela Fiengo; Giovanni Martinotti; Laura Orsolini; Alessandro Valchera; Massimo Di Giannantonio; Andrea de Bartolomeis
Journal:  Int J Mol Sci       Date:  2017-01-12       Impact factor: 5.923

7.  Synapse Pathology in Schizophrenia: A Meta-analysis of Postsynaptic Elements in Postmortem Brain Studies.

Authors:  Amber Berdenis van Berlekom; Cita H Muflihah; Gijsje J L J Snijders; Harold D MacGillavry; Jinte Middeldorp; Elly M Hol; René S Kahn; Lot D de Witte
Journal:  Schizophr Bull       Date:  2020-02-26       Impact factor: 9.306

8.  Transcriptional profile of pyramidal neurons in chronic schizophrenia reveals lamina-specific dysfunction of neuronal immunity.

Authors:  Xiaojun Wu; Rammohan Shukla; Khaled Alganem; Xiaolu Zhang; Hunter M Eby; Emily A Devine; Erica Depasquale; James Reigle; Micah Simmons; Margaret K Hahn; Christy Au-Yeung; Roshanak Asgariroozbehani; Chang-Gyu Hahn; Vahram Haroutunian; Jarek Meller; James Meador-Woodruff; Robert E McCullumsmith
Journal:  Mol Psychiatry       Date:  2021-07-16       Impact factor: 15.992

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.